CSRxP: FABRIZIO WARD SURVEY FINDS AMERICAN VOTERS OVERWHELMING HOLD BIG PHARMA COMPANIES RESPONSIBLE FOR HIGH DRUG PRICES
Voters Across the Political Spectrum Identify Pharmaceutical Company Profits… Read More
© 2026 CSRXP- All Rights Reserved
SECOND OPINION: PhRMA REDUXES SAME DEBUNKED ARGUMENTS ON INNOVATION
Big Pharma’s Innovation Rhetoric Designed to Keep Drug Prices High Rather… Read More
THEY SAID IT! PRESIDENT TRUMP CALLS OUT BIG PHARMA’S EGREGIOUS PRICING FOR DIABETES AND WEIGHT LOSS DRUGS IN U.S. MARKET
Brand Name Manufacturers’ Prices for Blockbuster GLP-1 Medications Are… Read More
CSRxP STATEMENT ON CONFIRMATION OF RFK JR AS SECRETARY OF U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES
Campaign Looks Forward to Working with Kennedy and the Administration to Lower… Read More
BIG PHARMA EARNINGS WATCH: GILEAD
Brand Name Drug Company Known for Egregious Product-Hopping Strategy Beats… Read More
BIG PHARMA EARNINGS WATCH: ASTRAZENECA, BRISTOL MYERS SQUIBB AND ELI LILLY
Eli Lilly Signals Plan to Maintain Unsustainably High Prices on Blockbuster… Read More
BIG PHARMA EARNINGS WATCH: MERCK AND PFIZER
Pharmaceutical Giants Continue to Outperform Wall Street Projections While… Read More
BIG PHARMA EARNINGS WATCH: AMGEN, GSK AND NOVO NORDISK
Major Pharmaceutical Companies Continue Growing Revenues While Sticking With… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE, NOVARTIS AND ROCHE
Big Pharma Giants Report Higher-Than-Expected Q4 Earnings Amid Continued Price… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Johnson & Johnson Beats Wall Street Analysts’ Expectations Fueled by… Read More
BIG PHARMA WATCH: MERCK EXPEDITES ANTI-COMPETITIVE STRATEGY ON BLOCKBUSTER CANCER DRUG
Big Pharma Giant’s Patent Abuse Scheme for Keytruda Will Extend Monopoly… Read More
ICYMI: INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW ANNOUNCES ANNUAL LAUNCH PRICE AND ACCESS REPORT FOR 2025
New Analysis Will Help Shine a Light on Big Pharma’s Increasingly… Read More